[Form 3] Cigna Group Initial Statement of Beneficial Ownership

Rhea-AI Filing Summary

Koka Durga Prasad, Executive Vice President and Global CIO of Cigna Group (CI), filed an initial Form 3 reporting ownership after a qualifying event on 09/08/2025. The filing shows 4,324 shares of common stock held directly and five employee stock option grants covering 4,610 underlying shares (638, 634, 842, 1,137, 1,359) with exercise prices from $218.2525 to $336.475 and various exercisable/expiration dates through 2035. The form was signed by Elise Ryan, attorney-in-fact, on 09/17/2025.

Positive

• Direct equity ownership reported: 4,324 shares of Cigna common stock are disclosed
• Detailed option grants and vesting are provided with exercise prices and expirations through 2035
• Form filed and signed by attorney-in-fact (Elise Ryan) with dates included

Negative

• None.

Insights

Securities Analyst

TL;DR: Routine Section 16 filing shows officer equity ownership via shares and multiple option grants; no unusual transactions disclosed.

The Form 3 is an initial beneficial-ownership disclosure for an executive officer, listing direct ownership of 4,324 common shares and five employee stock options totaling 4,610 underlying shares with exercise prices and expirations stated. All holdings are reported as direct (D). This filing is informational and customary when an officer becomes a reporting person.

Corporate Governance Expert

TL;DR: Governance disclosure completed properly; grants and vesting schedules are documented and signatures included.

The document includes vesting and grant dates for each option and explains installment vesting schedules. The reporting includes an attorney-in-fact signature and required dates, satisfying procedural requirements for initial Section 16 filings. There are no amendments, derivatives beyond standard employee options, or indirect ownership claims noted.

SEC Form 3

FORM 3

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0104
Estimated average burden
hours per response:			0.5

1. Name and Address of Reporting Person^*

Koka Durga Prasad

(Last) (First) (Middle)

900 COTTAGE GROVE RD

(Street)

BLOOMFIELD CT 06002

(City) (State) (Zip)

2. Date of Event Requiring Statement (Month/Day/Year)
09/08/2025

3. Issuer Name and Ticker or Trading Symbol
Cigna Group [ CI ]

4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	EVP, Global CIO

5. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4)	2. Amount of Securities Beneficially Owned (Instr. 4)	3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	4. Nature of Indirect Beneficial Ownership (Instr. 5)
Common Stock, $.01 Par Value	4,324	D

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4)	2. Date Exercisable and Expiration Date (Month/Day/Year)		3. Title and Amount of Securities Underlying Derivative Security (Instr. 4)		4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Employee Stock Option (Right to Buy)	11/05/2022(1)	11/05/2031	Common Stock, $.01 Par Value	638	$218.2525	D
Employee Stock Option (Right to Buy)	03/01/2023(2)	02/23/2032	Common Stock, $.01 Par Value	634	$227.02	D
Employee Stock Option (Right to Buy)	03/01/2024(3)	02/22/2033	Common Stock, $.01 Par Value	842	$294.61	D
Employee Stock Option (Right to Buy)	03/01/2025(4)	02/28/2034	Common Stock, $.01 Par Value	1,137	$336.475	D
Employee Stock Option (Right to Buy)	03/01/2026(5)	02/28/2035	Common Stock, $.01 Par Value	1,359	$305.855	D

Explanation of Responses:

1. This option was granted on November 5, 2021. The option vested in three equal annual installments beginning November 5, 2022.

2. This option was granted on February 23, 2022. The option vested in three equal annual installments beginning March 1, 2023.

3. This option was granted on February 22, 2023 and vests in three equal annual installments. The first two installments became exercisable on March 1, 2024 and March 1, 2025, and the last installment becomes exercisable on March 1, 2026.

4. This option was granted on February 22, 2024, and vests in three equal annual installments. The first installment became exercisable on March 1, 2025, and the next two installments become exercisable on March 1, 2026 and March 1, 2027.

5. 5. This option vests in three equal annual installments beginning March 1, 2026.

Remarks:

	Elise Ryan, attorney-in-fact	09/17/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What did Koka Durga Prasad report on the Form 3 for Cigna (CI)?

The Form 3 reports 4,324 shares of common stock owned directly and five employee stock options covering 4,610 underlying shares with specified exercise prices and expiration dates.

When is the event date reported on the Form 3 for CI?

The Date of Event Requiring Statement is listed as 09/08/2025.

What are the exercise prices and expirations of the reported options?

Exercise prices range from $218.2525 to $336.475; expirations are between 11/05/2031 and 02/28/2035 as disclosed.

Are the reported holdings direct or indirect?

All listed common shares and derivative securities are reported as Direct (D) ownership.

Who signed the Form 3 and when?

The Form 3 was signed by Elise Ryan, attorney-in-fact on 09/17/2025.